- Price
- $72.09
- Day
- -0.07%
- Mkt Cap
- $11.29B
- 52W Range
- $43.20 – $72.37
- Volume
- 3.04M
- Beta
- 1.28
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
CMB.TECH FLEET UPDATE ANTWERP, Belgium, 3 August 2026, 08:00 CET – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) has sold one VLCC, generating a capital gain of approximately 74.4 million USD. Euronav CMB.TECH has sold the VLCC Donoussa (2016, 299,999 dwt).
Read full article
West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.
Read full article
The top five contributors for the quarter were MKS, Amphenol, Arista Networks, Bio-Techne, and Waters. The bottom five detractors for the quarter were Ross Stores, Arch Capital, Copart, Gartner, and Brown & Brown. We purchased shares in Verisk Analytics, the dominant provider of data and analytics to property and casualty insurers in the U.S.
Read full article
Bank of Nova Scotia reduced its position in shares of Bio-Techne Corp (NASDAQ: TECH) by 78.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,637 shares of the biotechnology company's stock after selling 38,334 shares during the period. Bank
Read full article
FHLC's 0.08% expense ratio and market-cap approach delivered stronger returns, while RSPH's equal-weight strategy offers lower volatility and broader diversification across 60 holdings.
Read full article
Dimensional Fund Advisors LP grew its position in Bio-Techne Corp (NASDAQ: TECH) by 10.0% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,973,136 shares of the biotechnology company's stock after purchasing an additional 178,843 shares during the quarter. Dimensional Fund
Read full article
(CSE: URAI / OTC: URAIF / FSE: 3QG0) [email protected] Highlights Inturai's DomeCommand platform selected in a highly selective first wave from over 450 applicants. Development advances with the European Defence Tech Hub and the Republic of Singapore Air Force.
Read full article
TECH heads into fiscal fourth-quarter earnings with revenues expected to remain flat, EPS projected to decline, and its $11.3 billion acquisition deal in focus.
Read full article
American Capital Management Inc. increased its position in shares of Bio-Techne Corp (NASDAQ: TECH) by 8.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,021,128 shares of the biotechnology company's stock after purchasing an additional 79,979 shares during the quarter.
Read full article
Bessemer Group Inc. lowered its stake in Bio-Techne Corp (NASDAQ: TECH) by 13.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 61,962 shares of the biotechnology company's stock after selling 9,722 shares during the quarter. Bessemer Group Inc.'s holdings in
Read full article
IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-weight approach posted a stronger 1-year return.
Read full article